Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.
Li, C., Zhan, W., Yang, Z., Tu, C., Hu, G., Zhang, X., Song, W., Du, S., Zhu, Y., Huang, K., Kong, Y., Zhang, M., Mao, Q., Gu, X., Zhang, Y., Xie, Y., Deng, Q., Song, Y., Chen, Z., Lu, L., Jiang, S., Wu, Y., Sun, L., Ying, T.(2022) Cell 185: 1389-1401.e18
- PubMed: 35344711 
- DOI: 10.1016/j.cell.2022.03.009
- Primary Citation of Related Structures:  
7WHI, 7WHJ, 7WHK - PubMed Abstract: 
The effectiveness of SARS-CoV-2 vaccines and therapeutic antibodies have been limited by the continuous emergence of viral variants and by the restricted diffusion of antibodies from circulation into the sites of respiratory virus infection. Here, we report the identification of two highly conserved regions on the Omicron variant receptor-binding domain recognized by broadly neutralizing antibodies ...